Scientists uncover two-pronged strategy to overcome glioblastoma's resistance to immunotherapy

Дата публикации: 08-10-2026 19:40:01

Scientists at The Wistar Institute have identified a combination treatment that overcomes two of the biggest barriers to immunotherapy in glioblastoma. In a study published in Neuro-Oncology, the researchers show that reprogramming myeloid cells, a type of immune cell that glioblastoma tumors co-opt to protect themselves, while simultaneously boosting cancer-fighting T cells shrank the tumors and prevented them from coming back.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Увеличена эффективность иммунотерапии против рака мозга	0	12.74	08-10-2026
2	Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma	0	15.89	10-09-2026
3	Making pediatric cancer more 'visible' boosts immunotherapy response	0	6.44	05-10-2026
4	New AI tool can predict where glioblastoma is most likely to return after initial surgery	0	5.59	28-09-2026
5	Scientists identify the neuroblastoma cells that signal poor outcomes	0	5.86	08-10-2026
6	Hidden “immune organ” in the skull may help fight brain cancer	0	5.41	17-09-2026
7	Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma	0	12.74	09-09-2026
8	Опухоль может строить собственное "гнездо" внутри мозга, выяснили ученые	0	7.9	28-09-2026
9	Making invisible cancers visible: A new route to turn 'cold' tumors 'hot'	0	7.83	17-09-2026
10	UCLA scientists turn cord blood into powerful cancer-fighting T cells	0	15.3	11-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.78. Источник: medicalxpress.com.